MRPS7 and nasopharyngeal carcinoma: Notably, these findings further propose that pharmacological targeting of the USP10-MRPS7/MRPS23-β-catenin signaling axis represents a promising precision medicine approach to inhibit metastatic dissemination and overcome cisplatin chemoresistance in advanced NPC.